PDS Biotech stock soars 15% as PDS0101 shows promise in data for HPV-positive cancers

Retrieved on: 2022-10-11 17:28:14

Tags for this article:

Click the tags to see associated articles and topics

PDS Biotech stock soars 15% as PDS0101 shows promise in data for HPV-positive cancers. View article details on hiswai:

Excerpt

PDS Biotechnology (PDSB) stock rose 14% on Oct. 11 after the company reported interim data from a phase 2 trial of PDS0101-based triple ...

Article found on: seekingalpha.com